Anondita Medicare Ltd vs Rudrabhishek Enterprises Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Anondita Medicare Ltd is ₹ 680.85 as of 20 Mar 15:30 . The P/E Ratio of Anondita Medicare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Rudrabhishek Enterprises Ltd changed from 26.2 on March 2021 to 21.3 on March 2025 . This represents a CAGR of -4.06% over 5 years The Market Cap of Anondita Medicare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Rudrabhishek Enterprises Ltd changed from ₹ 350.78 crore on March 2021 to ₹ 287.84 crore on March 2025 . This represents a CAGR of -3.88% over 5 years The revenue of Anondita Medicare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Rudrabhishek Enterprises Ltd for the Dec '25 is ₹ 21.46 crore as compare to the Sep '25 revenue of ₹ 22.22 crore. This represent the decline of -3.42% The ebitda of Anondita Medicare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Rudrabhishek Enterprises Ltd for the Dec '25 is ₹ 0.52 crore as compare to the Sep '25 ebitda of ₹ 2.87 crore. This represent the decline of -81.88% The net profit of Anondita Medicare Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Rudrabhishek Enterprises Ltd changed from ₹ 2.64 crore to ₹ -1.38 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Anondita Medicare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Rudrabhishek Enterprises Ltd changed from 5.04 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Anondita Medicare Ltd

Anondita Medicare Limited was incorporated as a Public Limited Company on March 12, 2024, with the Registrar of Companies, Central Registration Centre.
Prior to this, Company business was run by current promoter, Mr. Anupam Ghosh, as a sole proprietorship under the name of M/s Anondita Healthcare (formerly M/s Healthcare Products) from year 1999 onwards. Company is a manufacturer of male condoms with a variety of flavors, with our flagship product marketed and sold under the brand 'COBRA'.
It operate an installed production capacity of nearly 562 million condoms per annum, as per certificate issued by JP Sood, Chartered Engineer, dated November 21, 2024.
Further, to follow sustainable production practices, Company uses CNG as a clean, environmentally friendly manufacturing fuel for its manufacturing plant situated at Sector 80, Gautam Budh Nagar, Noida, Uttar Pradesh.

About Rudrabhishek Enterprises Ltd

Rudrabhishek Enterprises Limited was originally incorporated as a Private Limited Company with the name and style of 'Rudrabhishek Enterprises Private Limited' on September 01, 1992.
Subsequently, the Company was converted into a Public Company and the name of the Company was changed to 'Rudrabhishek Enterprises Limited' on November 03, 2017. The Company started operations in 1992.
Since incorporation, the Company was a service provider of end users.
The integrated services included Infrastructural Services, Urban Designing and planning, Global Information Systems, Building Designing Services and Project Management Services. The Company is primarily engaged in the business of providing all kind of consultancy services related with infrastructure, environment, urban designing, urban planning housing, GIS, BIM & Project Management, civil designing, construction management including civil, mechanical, electrical, and all other types of erection, commissioning projects, project trading and execution of projects on turnkey basis and carry out engineering, procurement and construction contracts and turnkey contracts including at design services for all types of building, infrastructure and urban development projects for private and government agencies.

FAQs for the comparison of Anondita Medicare Ltd and Rudrabhishek Enterprises Ltd

Which company has a larger market capitalization, Anondita Medicare Ltd or Rudrabhishek Enterprises Ltd?

Market cap of Anondita Medicare Ltd is 1,231 Cr while Market cap of Rudrabhishek Enterprises Ltd is 127 Cr

What are the key factors driving the stock performance of Anondita Medicare Ltd and Rudrabhishek Enterprises Ltd?

The stock performance of Anondita Medicare Ltd and Rudrabhishek Enterprises Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anondita Medicare Ltd and Rudrabhishek Enterprises Ltd?

As of March 23, 2026, the Anondita Medicare Ltd stock price is INR ₹680.85. On the other hand, Rudrabhishek Enterprises Ltd stock price is INR ₹70.44.

How do dividend payouts of Anondita Medicare Ltd and Rudrabhishek Enterprises Ltd compare?

To compare the dividend payouts of Anondita Medicare Ltd and Rudrabhishek Enterprises Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.